Abstract
Cancer stem cells, sometimes referred to as tumor initiating cells, play pivotal roles in tumor initiation, progression, metastasis, resistance to therapy, and relapse. Understanding how these populations of cells expand in response to a host of conditions is critical in determining effective cancer therapeutics. A defining feature of cancer stem cells is the ability to switch between modes of quiescence and symmetric/asymmetric division to protect and conserve the population, this feature is traditionally reserved for normal adult stem cell populations. Understanding how the core cell cycle machinery responds to external cues to drive symmetric/asymmetric division vs. quiescence will reveal fundamental information about how cancer stem cell populations survive and expand. This chapter will describe methods to study the cell cycle dynamics in brain cancer stem cell populations and how they compare to the other populations in a tumor.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Venere M, Fine HA, Dirks PB, Rich JN (2011) Cancer stem cells in gliomas: identifying and understanding the apex cell in cancer’s hierarchy. Glia 59:1148–1154
Alvarez-Buylla A, Lim D (2004) For the long run: maintaining germinal niches in the adult brain. Neuron 41:683–686
Guilak F, Cohen D, Estes B, Gimble J, Liedtke W et al (2009) Control of stem cell fate by physical interactions with the extracellular matrix. Cell Stem Cell 5:17–26
Li L, Clevers H (2010) Coexistence of quiescent and active adult stem cells in mammals. Science 327:542–545
Morrison SJ, Kimble J (2006) Asymmetric and symmetric stem-cell divisions in development and cancer. Nature 441:1068–1074
Shen Q, Goderie SK, Jin L, Karanth N, Sun Y et al (2004) Endothelial cells stimulate self-renewal and expand neurogenesis of neural stem cells. Science 304:1338–1340
Shahriyari L, Komarova NL (2013) Symmetric vs. asymmetric stem cell divisions: an adaptation against cancer? PLoS One 8(10):e76195
Yatabe Y, Tavaré S, Shibata D (2001) Investigating stem cells in human colon by using 618 methylation patterns. Proc Natl Acad Sci 98:10839–10844
Spradling A, Drummond-Barbosa D, Kai T (2001) Stem cells find their niche. Nature 414:98–104
Nicolas P, Kim KM, Shibata D, Tavaré S (2007) The stem cell population of the human colon crypt: analysis via methylation patterns. PLoS Comput Biol 3:e28
Norbury C, Nurse P (1992) Animal cell cycles and their control. Annu Rev Biochem 61:441–470
Zetterber A, Larsson O, Wiman KG (1995) What is the restriction point? Curr Opin Cell Biol 7(6):835–842
Cheung TH, Rando TA (2013) Molecular regulation of stem cell quiescence. Nat Rev Mol Cell Biol 14:329–340
Moore N, Lyle S (2011) Quiescent, slow-cycling stem cell populations in cancer: a review of the evidence and discussion of significance. J Oncol 2011:396076
Hemmati HD, Nakano I, Lazareff JA, Masterman-Smith M, Geschwind DH, Bronner-Fraser M, Kornblum HI (2003) Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci 100(25):15178–15183
Ignatova TN, Kukekov VG, Laywell ED, Suslov ON, Vrionis FD, Steindler DA (2002) Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro. Glia 39(3):193–206
Rosenblum ML, Gerosa M, Dougherty DV, Reese C, Barger GR, Davis RL, Levin VA, Wilson CB (1982) Age-related chemosensitivity of stem cells from human malignant brain tumours. Lancet 1(8277):885–887
Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, Dirks PB (2003) Identification of cancer stem cells in human brain tumors. Cancer Res 63(18):5821–5828
Campos B, Gal Z, Baader A, Schneider T, Sliwinski C, Gassel K (2014) Aberrant self-renewal and quiescence contribute to the aggressiveness of glioblastoma. J Pathol 234:23–33
Brescia P, Ortensi B, Fornasari L, Levi D, Broggi G, Pelicci G (2013) CD133 is essential for glioblastoma stem cell maintenance. Stem Cells 31:857–869
Zeppernick F, Ahmadi R, Campos B, Dictus C, Helmke BM, Becker N, Lichter P, Unterberg A, Radlwimmer B, Herold-Mende CC (2008) Stem cell marker CD133 affects clinical outcome in glioma patients. Clin Cancer Res 14:123–129
Han M, Guo L, Zhang Y, Huang B, Chen A, Chen W, Liu X, Sun S, Wang K, Liu A, Li X (2016) Clinicopathological and prognostic significance of CD133 in Glioma patients: a meta-analysis. Mol Neurobiol 53:720–727
Son MJ, Woolard K, Nam DH, Lee J, Fine HA (2009) SSEA-1 is an enrichment marker for tumor-initiating cells in human glioblastoma. Cell Stem Cell 4:440–452
Liu G, Yuan X, Zeng Z, Tunici P, Ng H, Abdulkadir IR, Lu L, Irvin D, Black KL, Yu JS (2006) Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Mol Cancer 5:67
Brown DV, Filiz G, Daniel PM, Hollande F, Dworkin S et al (2017) Expression of CD133 and CD44 in glioblastoma stem cells correlates with cell proliferation, phenotype stability and intra-tumor heterogeneity. PLoS One 12(2):e0172791
Bleau AM et al (2009) PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells. Cell Stem Cell 4:226–235
Darzynkiewicz Z, Huang X (2004) Analysis of cellular DNA content by flow cytometry. Curr Protoc Immunol 5:7 Chapter 5: Unit
Kim KH, Sederstrom JM (2015) Assaying cell cycle status using flow cytometry. Curr Protoc Mol Biol 111:28.6.1–28.6.11
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Qemo, I., Porter, L.A. (2019). Cell Cycle Dynamics in Glioma Cancer Stem Cells. In: Singh, S., Venugopal, C. (eds) Brain Tumor Stem Cells. Methods in Molecular Biology, vol 1869. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-8805-1_11
Download citation
DOI: https://doi.org/10.1007/978-1-4939-8805-1_11
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-8804-4
Online ISBN: 978-1-4939-8805-1
eBook Packages: Springer Protocols